Glioblastoma multiforme (GBM) is the most malignant primary tumour of the nervous system (CNS), with a very poor prognosis. The progression-free survival of patients with this condition after diagnosis is 6.2-7.5 months; the median survival is 14.6-16.7 months [1][2][3] and the 5-year survival rate is only 10%. 4 The current standard therapy for GBM is the maximal surgical resection with postoperative
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.